These results indicate that STAG2 is critical for SMC3 acetylation independent of p53 function, and that cancer cells with concomitant STAG2 and TP53 inactivation escape cellular senescence despite abrogation of SMC3 acetylation. The gene discussed is SMC3; the disease is cancer.